These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20038454)

  • 21. Target discovery from data mining approaches.
    Yang Y; Adelstein SJ; Kassis AI
    Drug Discov Today; 2009 Feb; 14(3-4):147-54. PubMed ID: 19135549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in top-down proteomics for disease biomarker discovery.
    Calligaris D; Villard C; Lafitte D
    J Proteomics; 2011 Jun; 74(7):920-34. PubMed ID: 21477672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent technological developments in proteomics shed new light on translational research on diabetic microangiopathy.
    Ma Y; Yang C; Tao Y; Zhou H; Wang Y
    FEBS J; 2013 Nov; 280(22):5668-81. PubMed ID: 23763694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in pharmacology and drug discovery.
    Anderson DC; Kodukula K
    Biochem Pharmacol; 2014 Jan; 87(1):172-88. PubMed ID: 24001556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers: refining diagnosis and expediting drug development - reality, aspiration and the role of open innovation.
    Salter H; Holland R
    J Intern Med; 2014 Sep; 276(3):215-28. PubMed ID: 24605903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What was old is new again: using the host response to diagnose infectious disease.
    Ko ER; Yang WE; McClain MT; Woods CW; Ginsburg GS; Tsalik EL
    Expert Rev Mol Diagn; 2015; 15(9):1143-58. PubMed ID: 26145249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.
    Visser SAG; Bueters TJH
    Eur J Pharm Sci; 2017 Nov; 109S():S72-S77. PubMed ID: 28811131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated approach toward the discovery of glyco-biomarkers of inflammation-related diseases.
    Angata T; Fujinawa R; Kurimoto A; Nakajima K; Kato M; Takamatsu S; Korekane H; Gao CX; Ohtsubo K; Kitazume S; Taniguchi N
    Ann N Y Acad Sci; 2012 Apr; 1253():159-69. PubMed ID: 22380786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational biomarkers: from discovery and development to clinical practice.
    Subramanyam M; Goyal J
    Drug Discov Today Technol; 2016; 21-22():3-10. PubMed ID: 27978985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From biomarker strategies to biomarker activities and back.
    van Gool AJ; Henry B; Sprengers ED
    Drug Discov Today; 2010 Feb; 15(3-4):121-6. PubMed ID: 19931413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of genomics, proteomics and metabolomics in drug discovery, development and clinic.
    Russell C; Rahman A; Mohammed AR
    Ther Deliv; 2013 Mar; 4(3):395-413. PubMed ID: 23442083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.
    Vaudano E; Vannieuwenhuyse B; Van Der Geyten S; van der Lei J; Visser PJ; Streffer J; Ritchie C; McHale D; Lovestone S; Hofmann-Apitius M; Truyen L; Goldman M
    Alzheimers Dement; 2015 Sep; 11(9):1121-2. PubMed ID: 25754460
    [No Abstract]   [Full Text] [Related]  

  • 36. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory Science - An Underappreciated Component of Translational Research.
    Rouse R; Zineh I; Strauss DG
    Trends Pharmacol Sci; 2018 Mar; 39(3):225-229. PubMed ID: 29329784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiolabelled probes targeting infection and inflammation for personalized medicine.
    Signore A; Lauri C; Galli F
    Curr Pharm Des; 2014; 20(14):2338-45. PubMed ID: 24025100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.
    Ramaiah SK; Walker DB
    Toxicol Pathol; 2016 Feb; 44(2):137-46. PubMed ID: 26839329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bioinformatics in diabetes drug development--and precision medicine.
    Dangi-Garimella S
    Am J Manag Care; 2014 May; 20(8 Spec No.):E1. PubMed ID: 25617937
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.